Shell Asset Management Co
- SEC CIK
- 0001211028
- Latest filing
- Nov 7, 2025
IOVA holding history
Iovance Biotherapeutics, Inc. in every 13F filed by Shell Asset Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IOVA overviewAll 13F holders of IOVAFull Q3 2025 holdings
- Shares (Q3 2025)
- 4,454
- Value
- $10.0K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 4,454 | $10.0K | <0.1% | −1,464−24.7% | Reduced | Holders |
| Q2 2025 | 5,918 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 5,918 | $20.0K | <0.1% | −246−4.0% | Reduced | Holders |
| Q4 2024 | 6,164 | $46.0K | <0.1% | −82−1.3% | Reduced | Holders |
| Q3 2024 | 6,246 | $59.0K | <0.1% | – | No prior filing | Holders |
| Q2 2024 | – | – | – | – | Not filed | Holders |
| Q1 2024 | 6,284 | $50.0K | <0.1% | −677−9.7% | Reduced | Holders |
| Q4 2023 | 6,961 | $57.0K | <0.1% | −2,091−23.1% | Reduced | Holders |
| Q3 2023 | 9,052 | $41.0K | <0.1% | −142−1.5% | Reduced | Holders |
| Q2 2023 | 9,194 | $65.0K | <0.1% | −53−0.6% | Reduced | Holders |
| Q1 2023 | 9,247 | $56.0K | <0.1% | −33−0.4% | Reduced | Holders |
| Q4 2022 | 9,280 | $59.0K | <0.1% | −1,884−16.9% | Reduced | Holders |
| Q3 2022 | 11,164 | $107.0K | <0.1% | −2,924−20.8% | Reduced | Holders |
| Q2 2022 | 14,088 | $156.0K | <0.1% | +23+0.2% | Added | Holders |
| Q1 2022 | 14,065 | $234.0K | <0.1% | −2,082−12.9% | Reduced | Holders |
| Q4 2021 | 16,147 | $308.0K | <0.1% | +78+0.5% | Added | Holders |
| Q3 2021 | 16,069 | $396.0K | <0.1% | −690−4.1% | Reduced | Holders |
| Q2 2021 | 16,759 | $436.0K | <0.1% | +16,759 | New | Holders |